BANGKOK - NewGenIVF Group Limited (NASDAQ:NIVF) announced Friday its plan to convert its Ras Al Khaimah Beach District luxury project from a joint venture to a joint development structure, while ...

ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

DENVER (KDVR) — An explosion destroyed a couple’s home in Dacono, north of Denver, on Tuesday. The explosion led to a fire that engulfed a mobile home at the end of the cul-de-sac on Glen Heather ...

Terminal near beachfront resorts to serve private jet travellers by early 2027 The new VVIP terminal, 8,000 sqm multi-purpose hangar, premium lounges, and helipad are set to open in Q1 2027. The Wynn ...

PESHAWAR: Vice-chancellor Khyber Medical University Prof Dr Ziaul Haq has been appointed executive director of Higher Education Commission (HEC) Islamabad. Prof Ziaul Haq is not only the youngest ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Forbes contributors publish independent expert analyses and insights. Vibhas Ratanjee studies leadership and culture at Gallup Career growth inside companies still follows a narrow script—progress ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Ras Baraka, the Democratic mayor of Newark, New Jersey, and a candidate for governor, appeared in federal court Thursday for a status conference after being arrested at an ICE facility last week on a ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...